ASXL1 and chronic myelogenous leukemia, BCR-ABL1 positive: On the other hand, patients carrying ASXL1 mutations at the time of diagnosis are often characterized as younger individuals facing a higher risk classification [13], indicating a role of clonal evolution associated with ASXL1 mutations in CML pathogenesis.